
CAS 1228591-30-7
:TAK-632
Description:
TAK-632, with the CAS number 1228591-30-7, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of cancer treatment. It is classified as a small molecule inhibitor, specifically targeting certain kinases involved in cellular signaling pathways that regulate cell growth and proliferation. The compound exhibits selective inhibition, which is crucial for minimizing off-target effects and enhancing therapeutic efficacy. TAK-632 has shown promise in preclinical studies for its potential to disrupt tumor growth and improve outcomes in various cancer models. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are essential for determining its suitability for clinical use. Additionally, ongoing research aims to elucidate its mechanism of action, optimal dosing regimens, and potential combination therapies with other anticancer agents. As with many investigational drugs, further studies are necessary to fully understand its safety profile and therapeutic potential in human subjects.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
N-[7-cyano-6-(4-fluoro-3-{2-[3-(trifluoromethyl)phenyl]acetamido}phenoxy)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide
CAS:Formula:C27H18F4N4O3SPurity:98%Color and Shape:SolidMolecular weight:554.5154TAK-632
CAS:TAK-632 is a potent pan-Raf inhibitor.Formula:C27H18F4N4O3SPurity:98% - 99.5%Color and Shape:SolidMolecular weight:554.52TAK 632
CAS:<p>Inhibitor of pan-Raf kinases</p>Formula:C27H18F4N4O3SPurity:Min. 95%Color and Shape:PowderMolecular weight:554.52 g/mol




